Insider Transactions in Q4 2022 at Resmed Inc (RSMDF)
Insider Transaction List (Q4 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 15
2022
|
Michael J. Farrell Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
5,675
-1.28%
|
$1,220,125
$215.63 P/Share
|
|
Dec 15
2022
|
Michael J. Farrell Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,675
+1.27%
|
$323,475
$57.76 P/Share
|
|
Dec 05
2022
|
David Pendarvis Chief Administrative Officer |
SELL
Open market or private sale
|
Direct |
1,500
-1.5%
|
$343,500
$229.81 P/Share
|
|
Nov 28
2022
|
David Pendarvis Chief Administrative Officer |
SELL
Bona fide gift
|
Direct |
7,300
-6.79%
|
-
|
|
Nov 25
2022
|
David Pendarvis Chief Administrative Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
683
+0.63%
|
$99,718
$146.34 P/Share
|
|
Nov 23
2022
|
David Pendarvis Chief Administrative Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
6,911
-6.08%
|
$1,548,064
$224.4 P/Share
|
|
Nov 23
2022
|
David Pendarvis Chief Administrative Officer |
BUY
Grant, award, or other acquisition
|
Direct |
12,389
+9.83%
|
-
|
|
Nov 23
2022
|
Michael J. Farrell Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
33,239
-7.07%
|
$7,445,536
$224.4 P/Share
|
|
Nov 23
2022
|
Michael J. Farrell Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
56,115
+10.66%
|
-
|
|
Nov 23
2022
|
Kaushik Ghoshal Chief Commercial Officer, SaaS |
SELL
Payment of exercise price or tax liability
|
Direct |
4,318
-20.54%
|
$967,232
$224.4 P/Share
|
|
Nov 23
2022
|
Kaushik Ghoshal Chief Commercial Officer, SaaS |
BUY
Grant, award, or other acquisition
|
Direct |
7,288
+25.74%
|
-
|
|
Nov 23
2022
|
Robert Andrew Douglas Special Advisor |
SELL
Payment of exercise price or tax liability
|
Direct |
19,425
-26.62%
|
$4,351,200
$224.4 P/Share
|
|
Nov 23
2022
|
Robert Andrew Douglas Special Advisor |
BUY
Grant, award, or other acquisition
|
Direct |
32,795
+31.0%
|
-
|
|
Nov 23
2022
|
Brett Sandercock Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
14,577
+10.76%
|
-
|
|
Nov 23
2022
|
Justin Leong Chief Product Officer |
BUY
Grant, award, or other acquisition
|
Direct |
6,924
+9.4%
|
-
|
|
Nov 22
2022
|
Justin Leong Chief Product Officer |
SELL
Open market or private sale
|
Direct |
3,777
-5.94%
|
$864,933
$229.5 P/Share
|
|
Nov 22
2022
|
Justin Leong Chief Product Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+19.09%
|
$855,000
$57.76 P/Share
|
|
Nov 21
2022
|
Lucile Blaise President, Sleep & RC Business |
SELL
Payment of exercise price or tax liability
|
Direct |
267
-1.32%
|
$59,808
$224.4 P/Share
|
|
Nov 16
2022
|
Jan De Witte Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,122
+15.51%
|
-
|
|
Nov 16
2022
|
John Hernandez Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,122
+35.06%
|
-
|
|
Nov 16
2022
|
Desney Tan Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,122
+35.06%
|
-
|
|
Nov 16
2022
|
Richard Sulpizio Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,122
+6.98%
|
-
|
|
Nov 16
2022
|
Ronald R Taylor Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,122
+5.11%
|
-
|
|
Nov 16
2022
|
Karen Drexler Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,122
+11.56%
|
-
|
|
Nov 16
2022
|
Harjit Gill Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,122
+13.38%
|
-
|
|
Nov 16
2022
|
Carol Burt Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,122
+35.06%
|
-
|
|
Nov 16
2022
|
Peter C Farrell Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,122
+0.62%
|
-
|
|
Nov 15
2022
|
Michael J. Farrell Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
5,675
-1.35%
|
$1,271,200
$224.64 P/Share
|
|
Nov 15
2022
|
Michael J. Farrell Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,675
+1.33%
|
$323,475
$57.76 P/Share
|
|
Nov 15
2022
|
Lucile Blaise President, Sleep & RC Business |
SELL
Open market or private sale
|
Direct |
169
-2.25%
|
$38,025
$225.18 P/Share
|
|
Nov 15
2022
|
Lucile Blaise President, Sleep & RC Business |
BUY
Exercise of conversion of derivative security
|
Direct |
516
+6.43%
|
$116,100
$225.18 P/Share
|
|
Nov 15
2022
|
Robert Andrew Douglas Special Advisor |
SELL
Open market or private sale
|
Direct |
11,280
-21.92%
|
$2,504,160
$222.07 P/Share
|
|
Nov 15
2022
|
Robert Andrew Douglas Special Advisor |
BUY
Exercise of conversion of derivative security
|
Direct |
18,032
+13.95%
|
$1,045,856
$58.24 P/Share
|
|
Nov 11
2022
|
Harjit Gill Director |
SELL
Payment of exercise price or tax liability
|
Direct |
41
-0.66%
|
$9,225
$225.18 P/Share
|
|
Nov 11
2022
|
Kaushik Ghoshal Chief Commercial Officer, SaaS |
SELL
Payment of exercise price or tax liability
|
Direct |
898
-3.11%
|
$202,050
$225.18 P/Share
|
|
Nov 11
2022
|
Michael J. Farrell Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
8,630
-0.69%
|
$1,941,750
$225.18 P/Share
|
|
Nov 11
2022
|
Robert Andrew Douglas Special Advisor |
SELL
Payment of exercise price or tax liability
|
Direct |
1,705
-2.46%
|
$383,625
$225.18 P/Share
|
|
Nov 11
2022
|
Peter C Farrell Director |
SELL
Payment of exercise price or tax liability
|
Direct |
128
-0.07%
|
$28,800
$225.18 P/Share
|
|
Nov 11
2022
|
David Pendarvis Chief Administrative Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,066
-0.35%
|
$239,850
$225.18 P/Share
|
|
Nov 10
2022
|
Michael J. Farrell Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
4,880
-100.0%
|
$1,073,600
$220.83 P/Share
|
|
Nov 10
2022
|
Michael J. Farrell Chief Executive Officer |
BUY
Bona fide gift
|
Indirect |
1,000
+17.01%
|
-
|
|
Nov 10
2022
|
Michael J. Farrell Chief Executive Officer |
SELL
Bona fide gift
|
Indirect |
1,000
-19.65%
|
-
|
|
Nov 07
2022
|
Brett Sandercock Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
4,000
-3.63%
|
$848,000
$212.02 P/Share
|
|
Nov 03
2022
|
David Pendarvis Chief Administrative Officer |
SELL
Open market or private sale
|
Direct |
1,545
-1.49%
|
$332,175
$215.23 P/Share
|
|
Oct 31
2022
|
Peter C Farrell Director |
SELL
Bona fide gift
|
Direct |
4,550
-2.49%
|
-
|
|
Oct 31
2022
|
Peter C Farrell Director |
SELL
Open market or private sale
|
Direct |
9,050
-4.71%
|
$2,000,050
$221.98 P/Share
|
|
Oct 17
2022
|
Michael J. Farrell Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
5,675
-1.33%
|
$1,214,450
$214.58 P/Share
|
|
Oct 17
2022
|
Michael J. Farrell Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,675
+1.31%
|
$323,475
$57.76 P/Share
|
|
Oct 14
2022
|
Robert Andrew Douglas Special Advisor |
SELL
Open market or private sale
|
Direct |
11,355
-24.45%
|
$2,441,325
$215.09 P/Share
|
|
Oct 14
2022
|
Robert Andrew Douglas Special Advisor |
BUY
Exercise of conversion of derivative security
|
Direct |
18,033
+15.2%
|
$1,045,914
$58.24 P/Share
|